Hunter Snyder
About Hunter Snyder
Hunter Snyder serves as the Senior Manager of Investor Relations and Communications at Deciphera Pharmaceuticals, a position he has held since 2022. He has a diverse background in communications and public relations, with previous roles at JPA Health, Kingston-Dwight Associates, and LaVoieHealthScience.
Current Role at Deciphera Pharmaceuticals
Hunter Snyder serves as the Senior Manager of Investor Relations and Communications at Deciphera Pharmaceuticals. He has held this position since 2022, contributing to the company's communication strategies and investor engagement efforts. The role is based in Waltham, Massachusetts, where Snyder utilizes his expertise to enhance the company's visibility and foster relationships with stakeholders.
Previous Experience in Investor Relations and Communications
Before his current role, Hunter Snyder worked at Deciphera Pharmaceuticals as the Manager of External Communications from 2020 to 2022. His experience also includes a position as Account Supervisor at JPA Health for two months in 2020, and he previously held the role of Senior Account Executive at the same firm from 2019 to 2020. These roles provided him with a solid foundation in managing communications and client relationships.
Educational Background in Communication
Hunter Snyder studied at Emerson College, where he earned a Bachelor’s Degree in Marketing Communication from 2012 to 2016. He furthered his education at Lasell University, obtaining a Certificate in Health Communication from 2018 to 2019. This educational background supports his professional focus on effective communication strategies within the healthcare sector.
Career Development in Communications
Snyder's career in communications began with roles such as Communications Associate at Kingston-Dwight Associates in 2016 and Public Relations Associate at McNeil, Gray & Rice for five months in the same year. He also gained experience as an Assistant Consultant at Text100 in 2018 and progressed to Senior Account Executive at LaVoieHealthScience from 2018 to 2019. These positions contributed to his development in strategic communication and public relations.